PTC-821

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePTC-821
Drug Alias NamePTC-821
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBombesin receptor antagonists
TargetsBombesin receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArana Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArana Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A